COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 3001: Articles 30001-30010  | Next

Impact of city and residential unit lockdowns on prevention and control of COVID-19
Shao, P.
10.1101/2020.03.13.20035253 — Posted: 2020-03-17
Deep Learning-based Detection for COVID-19 from Chest CT using Weak Label
Zheng, C., Deng, X., Fu, Q., Zhou, Q., Feng, J., Ma, H., Liu, W., Wang, X.
10.1101/2020.03.12.20027185 — Posted: 2020-03-17
If containment is not possible, how do we minimize mortality for COVID-19 and other emerging infectious disease outbreaks?
Handel, A., Miller, J., Ge, Y., Fung, I. C.-H.
10.1101/2020.03.13.20034892 — Posted: 2020-03-17
Knowledge and perceptions of coronavirus disease 2019 among the general public in the United States and the United Kingdom: A cross-sectional online survey
Geldsetzer, P.
10.1101/2020.03.13.20035568 — Posted: 2020-03-17
Mental health status among family members of health care workers in Ningbo, China during the Coronavirus Disease 2019 (COVID-19) outbreak: a Cross-sectional Study
Ying, Y., Kong, F., Zhu, B., Ji, Y., Lou, Z., Ruan, L.
10.1101/2020.03.13.20033290 — Posted: 2020-03-17 Discussion: Onsite
Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model
Rockx, B., Kuiken, T., Herfst, S., Bestebroer, T., Lamers, M., de Meulder, D., van Amerongen, G., van de Brand, J., Okba, N., Schipper, D., van Run, P., Leijten, L., Verschoor, E., Verstrepen, B., Langermans, J., Drosten, C., Fentener van Vlissingen, M., Fouchier, R., de Swart, R. L., Koopmans, M., Haagmans, B.
10.1101/2020.03.17.995639 — Posted: 2020-03-17 Discussion: Onsite
Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols
Kratzel, A., Todt, D., V'kovski, P., Steiner, S., Gultom, M. L., Thao, T. T. N., Ebert, N., Holwerda, M., Steinmann, J., Niemeyer, D., Dijkman, R., Kampf, G., Drosten, C., Steinmann, E., Thiel, V., Pfaender, S.
10.1101/2020.03.10.986711 — Posted: 2020-03-17 Discussion: Onsite
Multiple approaches for massively parallel sequencing of HCoV-19 genomes directly from clinical samples
Xiao, M., Liu, X., Ji, J., Li, M., Li, J., Yang, L., Sun, W., Ren, P., Yang, G., Zhao, J., Liang, T., Ren, H., Chen, T., Zhong, H., Song, W., Wang, Y., Deng, Z., Zhao, Y., Ou, Z., Wang, D., Cai, J., Cheng, X., Feng, T., Wu, H., Gong, Y., Yang, H., Wang, J., Xu, X., Zhu, S., Chen, F., Zhang, Y., Chen, W., Li, Y., Li, J.
10.1101/2020.03.16.993584 — Posted: 2020-03-17
Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids
Zhao, B., Ni, C., Gao, R., Wang, Y., Yang, L., Wei, J., Lv, T., Liang, J., Zhang, Q., Xu, W., Xie, Y., Wang, X., Yuan, Z., Liang, J., Zhang, R., Lin, X.
10.1101/2020.03.16.990317 — Posted: 2020-03-17 Discussion: Onsite
Master Regulator Analysis of the SARS-CoV-2/Human interactome
Guzzi, P. H., Mercatelli, D., Ceraolo, C., Giorgi, F. M.
10.1101/2020.03.15.992925 — Posted: 2020-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).